Free tool
Stocks near their 52-week high
We cover 246 companies trading within 5% of their own 52-week high. The median market value in the group is $4.21B. Across the group, the median move over the past trading day is 0.00%. 99% of the 238 with a 200-day average trade above it. Price change over the past year runs from +11.3% to +190.2% across the middle 80 percent of the group, with a median of +47.8%. Across the group, 6 companies currently carry a tier A volume signal.
Other lists in this group
Table
246 of 3,992 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| LLY.DE | Eli Lilly and Company | $1.07T | Mega cap | +73.55% |
| JNJ | Johnson & Johnson | $658.24B | Mega cap | +55.40% |
| JNJB34.SA | Johnson & Johnson | $658.09B | Mega cap | +47.82% |
| JNJ.DE | Johnson & Johnson | $651.71B | Mega cap | +58.93% |
| 4AB.DE | AbbVie Inc. | $471.29B | Mega cap | +32.34% |
| ABBV | AbbVie Inc. | $469.68B | Mega cap | +29.36% |
| ABBV34.SA | AbbVie Inc. | $467.00B | Mega cap | +21.88% |
| MRCK34.SA | Merck & Co., Inc. | $388.60B | Mega cap | +81.07% |
| 6MK.DE | Merck & Co., Inc. | $379.64B | Mega cap | +91.49% |
| MRK | Merck & Co., Inc. | $377.72B | Mega cap | +86.85% |
| RHO.DE | Roche Holding AG | $370.84B | Mega cap | +41.42% |
| AMGN34.SA | Amgen Inc. | $239.09B | Mega cap | +47.79% |
| AMGN | Amgen Inc. | $238.06B | Mega cap | +56.24% |
| AMG.DE | Amgen Inc. | $237.76B | Mega cap | +60.12% |
| TMO | Thermo Fisher Scientific Inc. | $234.31B | Mega cap | +30.17% |
| TN8.DE | Thermo Fisher Scientific Inc. | $234.00B | Mega cap | +29.67% |
| GIS.DE | Gilead Sciences, Inc. | $184.35B | Large cap | +33.64% |
| PFIZ34.SA | Pfizer Inc. | $161.53B | Large cap | +11.58% |
| PFE | Pfizer Inc. | $161.30B | Large cap | +18.72% |
| PFE.DE | Pfizer Inc. | $161.11B | Large cap | +22.96% |
| VX1.DE | Vertex Pharmaceuticals Incorporated | $139.82B | Large cap | +41.64% |
| BMYB34.SA | Bristol-Myers Squibb Company | $138.65B | Large cap | +40.74% |
| VRTX | Vertex Pharmaceuticals Incorporated | $138.63B | Large cap | +40.66% |
| BMY | Bristol-Myers Squibb Company | $138.03B | Large cap | +47.01% |
| REGN34.SA | Regeneron Pharmaceuticals, Inc. | $85.16B | Large cap | +33.80% |
| REGN | Regeneron Pharmaceuticals, Inc. | $83.89B | Large cap | +39.36% |
| ARGX | argenx SE | $65.51B | Large cap | +47.90% |
| A1RG34.SA | argenx SE | $63.16B | Large cap | +36.97% |
| 0QF.DE | Moderna, Inc. | $59.07B | Large cap | +550.51% |
| TAK | Takeda Pharmaceutical Company Limited | $58.60B | Large cap | +22.68% |
| 4502.T | Takeda Pharmaceutical Company Limited | $58.08B | Large cap | +36.03% |
| TAKP34.SA | Takeda Pharmaceutical Company Limited | $57.22B | Large cap | +18.03% |
| C1AH34.SA | Cardinal Health, Inc. | $55.77B | Large cap | +52.41% |
| BDX | Becton, Dickinson and Company | $51.81B | Large cap | +25.97% |
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.59% |
| RVMD | Revolution Medicines, Inc. | $46.18B | Large cap | +466.35% |
| T1EV34.SA | Teva Pharmaceutical Industries Limited | $44.24B | Large cap | +94.70% |
| TEVA | Teva Pharmaceutical Industries Limited | $44.19B | Large cap | +110.08% |
| A | Agilent Technologies, Inc. | $43.80B | Large cap | +31.46% |
| IQV | IQVIA Holdings Inc. | $43.04B | Large cap | +38.51% |
| QTS.DE | IQVIA Holdings Inc. | $43.01B | Large cap | −4.04% |
| ONC | BeOne Medicines AG | $42.58B | Large cap | +25.21% |
| WAT | Waters Corporation | $40.67B | Large cap | +40.57% |
| 4578.T | Otsuka Holdings Co., Ltd. | $40.39B | Large cap | +57.62% |
| RPRX | Royalty Pharma plc | $35.71B | Large cap | +74.00% |
| I1LM34.SA | Illumina, Inc. | $34.10B | Large cap | +113.13% |
| ILU.DE | Illumina, Inc. | $34.08B | Large cap | +129.80% |
| ILMN | Illumina, Inc. | $33.95B | Large cap | +125.88% |
| D1EX34.SA | DexCom, Inc. | $33.75B | Large cap | +9.64% |
| DXCM | DexCom, Inc. | $33.65B | Large cap | +16.47% |
| DC4.DE | DexCom, Inc. | $33.35B | Large cap | +21.06% |
| BIIB | Biogen Inc. | $32.66B | Large cap | +62.12% |
| C1NC34.SA | Centene Corporation | $32.65B | Large cap | +116.61% |
| BIIB34.SA | Biogen Inc. | $32.56B | Large cap | +47.86% |
| IDP.DE | Biogen Inc. | $32.39B | Large cap | +65.32% |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +21.14% |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.12% |
| ROIV | Roivant Sciences Ltd. | $26.55B | Large cap | +206.51% |
| INCY | Incyte Corporation | $25.97B | Large cap | +51.01% |
| I1NC34.SA | Incyte Corporation | $25.83B | Large cap | +41.91% |
| GH | Guardant Health, Inc. | $22.94B | Large cap | +169.17% |
| THC | Tenet Healthcare Corporation | $21.89B | Large cap | +50.70% |
| GMAB | Genmab A/S | $21.42B | Large cap | +36.20% |
| GMAB.CO | Genmab A/S | $20.69B | Large cap | +36.19% |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | $16.99B | Large cap | +61.26% |
| IPN.PA | Ipsen S.A. | $15.97B | Large cap | +40.80% |
| SOLV | Solventum Corporation | $15.58B | Large cap | +25.57% |
| FPH.AX | Fisher & Paykel Healthcare Corporation Limited | $15.44B | Large cap | +11.27% |
| ESF0.DE | Eurofins Scientific SE | $14.67B | Large cap | +12.65% |
| ERF.PA | Eurofins Scientific SE | $14.64B | Large cap | +15.60% |
| 7733.T | Olympus Corporation | $14.46B | Large cap | +27.06% |
| CRL | Charles River Laboratories International, Inc. | $14.09B | Large cap | +81.27% |
| EXEL | Exelixis, Inc. | $14.05B | Large cap | +45.68% |
| RVTY | Revvity, Inc. | $13.93B | Large cap | +42.93% |
| ORNBV.HE | Orion Oyj | $13.16B | Large cap | +21.01% |
| ORNAV.HE | Orion Oyj | $13.11B | Large cap | +21.27% |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | $12.57B | Large cap | +1.80% |
| B1MR34.SA | BioMarin Pharmaceutical Inc. | $12.54B | Large cap | +4.97% |
| HALO | Halozyme Therapeutics, Inc. | $12.41B | Large cap | +46.30% |
| T1CH34.SA | Bio-Techne Corporation | $11.51B | Large cap | +23.42% |
| TECH | Bio-Techne Corporation | $11.35B | Large cap | +29.33% |
| PRAX | Praxis Precision Medicines, Inc. | $10.54B | Large cap | +704.28% |
| KYMR | Kymera Therapeutics, Inc. | $10.53B | Large cap | +197.09% |
| BIO | Bio-Rad Laboratories, Inc. | $10.40B | Large cap | +32.71% |
| HSIC | Henry Schein, Inc. | $10.30B | Large cap | +31.02% |
| RGEN | Repligen Corporation | $10.25B | Large cap | +51.67% |
| APGE | Apogee Therapeutics, Inc. | $10.21B | Large cap | +257.11% |
| RHCPA.AX | Ramsay Health Care Limited | $10.16B | Large cap | +1.45% |
| NUVL | Nuvalent Inc | $9.79B | Mid cap | +62.83% |
| BIO-B | Bio-Rad Laboratories, Inc. | $9.77B | Mid cap | +47.78% |
| TWST | Twist Bioscience Corporation | $9.41B | Mid cap | +451.89% |
| DEMANT.CO | Demant A/S | $9.36B | Mid cap | +17.12% |
| IMVT | Immunovant, Inc. | $9.07B | Mid cap | +189.13% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.00B | Mid cap | +179.08% |
| HQY | HealthEquity, Inc. | $8.75B | Mid cap | +18.69% |
| TXG | 10x Genomics, Inc. | $8.37B | Mid cap | +358.35% |
| RHC.AX | Ramsay Health Care Limited | $8.27B | Mid cap | +50.11% |
| SRRK | Scholar Rock Holding Corporation | $7.31B | Mid cap | +74.18% |
| 6869.T | Sysmex Corporation | $7.28B | Mid cap | +3.66% |
| HNGE | Hinge Health, Inc. | $7.25B | Mid cap | +56.66% |
| CHE | Chemed Corporation | $7.11B | Mid cap | +20.79% |
| GETI-B.ST | Getinge AB (publ) | $7.01B | Mid cap | +20.89% |
| CGON | CG Oncology, Inc. | $6.95B | Mid cap | +196.15% |
| E2XE34.SA | Exelixis, Inc. | $6.61B | Mid cap | +23.92% |
| HLUN-A.CO | H. Lundbeck A/S | $6.40B | Mid cap | +29.71% |
| CNTA | Centessa Pharmaceuticals plc | $6.27B | Mid cap | +143.24% |
| TVTX | Travere Therapeutics, Inc. | $6.24B | Mid cap | +284.86% |
| TFX | Teleflex Incorporated | $5.88B | Mid cap | +8.06% |
| SHC | Sotera Health Company | $5.58B | Mid cap | +18.42% |
| MMSI | Merit Medical Systems, Inc. | $5.44B | Mid cap | −0.28% |
| ACAD | ACADIA Pharmaceuticals Inc. | $5.07B | Mid cap | +11.33% |
| DYN | Dyne Therapeutics, Inc. | $4.92B | Mid cap | +93.26% |
| HAE | Haemonetics Corporation | $4.85B | Mid cap | +93.71% |
| ELVN | Enliven Therapeutics, Inc. | $4.46B | Mid cap | +194.32% |
| CON | Concentra Group Holdings Parent, Inc. | $4.44B | Mid cap | +50.93% |
| HTFL | Heartflow, Inc. | $4.26B | Mid cap | +40.79% |
| ITGR | Integer Holdings Corporation | $4.25B | Mid cap | +15.84% |
| ADPT | Adaptive Biotechnologies Corporation | $4.18B | Mid cap | +101.70% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | $4.08B | Mid cap | +1.26% |
| IDYA | IDEAYA Biosciences, Inc. | $4.01B | Mid cap | +66.32% |
| ABCL | AbCellera Biologics Inc. | $3.97B | Mid cap | +181.38% |
| RCUS | Arcus Biosciences, Inc. | $3.92B | Mid cap | +191.29% |
| BBZA.DE | BB Biotech AG | $3.87B | Mid cap | +7.22% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.85B | Mid cap | +55.97% |
| OGN | Organon & Co. | $3.62B | Mid cap | +50.67% |
| IMNM | Immunome, Inc. | $3.34B | Mid cap | +188.94% |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.97B | Mid cap | +73.50% |
| ATAI | AtaiBeckley Inc. | $2.74B | Mid cap | +61.71% |
| AXGN | AxoGen, Inc. Common Stock | $2.68B | Mid cap | +219.58% |
| PGEN | Precigen, Inc. | $2.65B | Mid cap | +61.66% |
| CDNA | CareDx, Inc. | $2.64B | Mid cap | +283.45% |
| PHVS | Pharvaris N.V. | $2.60B | Mid cap | +55.59% |
| BV3.DE | Bavarian Nordic A/S | $2.55B | Mid cap | +15.65% |
| RAPP | Rapport Therapeutics, Inc. | $2.52B | Mid cap | +250.70% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | $2.45B | Mid cap | +70.53% |
| ATRC | AtriCure, Inc. | $2.45B | Mid cap | +29.14% |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.31B | Mid cap | +4.23% |
| NEO | NeoGenomics, Inc. | $2.26B | Mid cap | +145.34% |
| ADUS | Addus HomeCare Corporation | $2.25B | Mid cap | +4.50% |
| PVLA | Palvella Therapeutics, Inc. | $2.22B | Mid cap | +173.39% |
| MD | Pediatrix Medical Group, Inc. | $2.19B | Mid cap | +56.87% |
| ZYME | Zymeworks Inc. | $2.10B | Mid cap | +96.28% |
| SEM | Select Medical Holdings Corp | $2.05B | Mid cap | +28.14% |
| 6960.T | Fukuda Denshi Co., Ltd. | $2.02B | Mid cap | +79.12% |
| VIMIAN.ST | Vimian Group AB (publ) | $1.99B | Small cap | +12.01% |
| VIR | Vir Biotechnology, Inc. | $1.87B | Small cap | +111.85% |
| BLFS | BioLife Solutions, Inc. | $1.82B | Small cap | +45.50% |
| ATT.ST | Attendo AB (publ) | $1.77B | Small cap | +80.74% |
| FBRX | Forte Biosciences, Inc. | $1.63B | Small cap | +589.87% |
| PYC.AX | PYC Therapeutics Limited | $1.60B | Small cap | +74.42% |
| A2RR34.SA | Arrowhead Pharmaceuticals, Inc. | $1.58B | Small cap | +298.89% |
| LBRX | LB Pharmaceuticals Inc | $1.55B | Small cap | +178.41% |
| REPL | Replimune Group, Inc. | $1.50B | Small cap | +187.16% |
| SPTX | Seaport Therapeutics, Inc. | $1.49B | Small cap | +40.32% |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +188.15% |
| AMBEA.ST | Ambea AB (publ) | $1.45B | Small cap | +38.66% |
| KALV | KalVista Pharmaceuticals Inc | $1.44B | Small cap | +98.68% |
| ANRO | Alto Neuroscience, Inc. | $1.43B | Small cap | +786.65% |
| MGTX | MeiraGTx Holdings plc | $1.43B | Small cap | +100.54% |
| DRTS | Alpha Tau Medical Ltd. | $1.38B | Small cap | +343.92% |
| 3148.T | Create SD Holdings Co., Ltd. | $1.38B | Small cap | +1.90% |
| NUTX | Nutex Health Inc. | $1.34B | Small cap | +118.22% |
| CRON.TO | Cronos Group Inc. | $1.31B | Small cap | +39.83% |
| CRON | Cronos Group Inc. | $1.31B | Small cap | +38.67% |
| 6523.T | PHC Holdings Corporation | $1.21B | Small cap | +58.42% |
| AVNS | Avanos Medical Inc | $1.17B | Small cap | +110.53% |
| J2AZ34.SA | Jazz Pharmaceuticals plc | $1.08B | Small cap | +35.66% |
| ABUS | Arbutus Biopharma Corporation | $1.03B | Small cap | +42.19% |
| CADL | Candel Therapeutics, Inc. | $1.02B | Small cap | +124.70% |
| B2RK34.SA | Bruker Corporation | $906.52M | Small cap | +63.27% |
| TALK | Talkspace, Inc. | $870.57M | Small cap | +93.73% |
| ACHV | Achieve Life Sciences, Inc. | $851.00M | Small cap | +177.52% |
| AMS.L | Advanced Medical Solutions Group plc | $830.96M | Small cap | +38.01% |
| UU8.F | Neurogene Inc. | $795.50M | Small cap | +165.60% |
| VREX | Varex Imaging Corporation | $778.90M | Small cap | +61.40% |
| 4588.T | Oncolys BioPharma Inc. | $753.78M | Small cap | +539.50% |
| SOPH | SOPHiA GENETICS SA | $726.14M | Small cap | +156.16% |
| OABI | OmniAb, Inc. | $699.33M | Small cap | +198.76% |
| 7575.T | Japan Lifeline Co., Ltd. | $694.70M | Small cap | +12.02% |
| GUD.TO | Knight Therapeutics Inc. | $690.78M | Small cap | +50.39% |
| SGMT | Sagimet Biosciences Inc. | $675.04M | Small cap | +39.59% |
| ANGO | AngioDynamics, Inc. | $648.51M | Small cap | +56.74% |
| CTNM | Contineum Therapeutics, Inc. | $640.31M | Small cap | +70.03% |
| 6197.T | Solasto Corporation | $635.28M | Small cap | +136.68% |
| EOLS | Evolus, Inc. | $579.92M | Small cap | +15.83% |
| 2664.T | Cawachi Limited | $531.16M | Small cap | +38.25% |
| PRLD | Prelude Therapeutics Incorporated | $522.47M | Small cap | +412.50% |
| 7979.T | Shofu Inc. | $517.24M | Small cap | +21.34% |
| 3151.T | Vital KSK Holdings, Inc. | $501.27M | Small cap | +40.44% |
| PBYI | Puma Biotechnology, Inc. | $472.84M | Small cap | +79.61% |
| KSI.TO | kneat.com, inc. | $452.27M | Small cap | +19.93% |
| HNSA.ST | Hansa Biopharma AB (publ) | $450.66M | Small cap | +35.65% |
| FRX.TO | Fennec Pharmaceuticals Inc. | $429.52M | Small cap | +36.00% |
| 5889.T | JAPAN EYEWEAR HOLDINGS CO LTD | $397.43M | Small cap | +27.04% |
| TBRG | TruBridge Inc | $393.58M | Small cap | +30.42% |
| EGTX.ST | Egetis Therapeutics AB (publ) | $390.51M | Small cap | +51.35% |
| CGS.AX | Cogstate Limited | $376.22M | Small cap | +85.76% |
| HUM.ST | Humana AB (publ) | $350.23M | Small cap | +81.84% |
| IKT | Inhibikase Therapeutics, Inc. | $347.44M | Small cap | +39.11% |
| RCEL | AVITA Medical, Inc. | $327.52M | Small cap | +133.77% |
| AVH.AX | AVITA Medical, Inc. | $324.65M | Small cap | +106.12% |
| SMTI | Sanara MedTech Inc. | $318.55M | Small cap | +2.09% |
| ANCR.L | Animalcare Group PLC | $314.33M | Small cap | +28.86% |
| MED.DE | MEDICLIN Aktiengesellschaft | $301.82M | Small cap | +75.81% |
| BDSX | Biodesix, Inc. | $296.22M | Small cap | +225.53% |
| TRMED.OL | Thor Medical ASA | $268.94M | Small cap | +135.13% |
| XUP.DE | Genfit S.A. | $258.22M | Small cap | +166.82% |
| ORMP | Oramed Pharmaceuticals Inc. | $218.55M | Small cap | +159.19% |
| AOTI.L | AOTI, Inc. | $205.47M | Small cap | +159.09% |
| LIK.DE | LIMES Schlosskliniken AG | $199.75M | Small cap | +70.66% |
| 4671.T | FALCO HOLDINGS Co., Ltd. | $180.64M | Small cap | +21.78% |
| ASRT | Assertio Holdings Inc | $151.86M | Small cap | +103.46% |
| EMPG | Empro Group Inc | $143.05M | Small cap | +76.60% |
| LOVE.TO | Cannara Biotech Inc. | $141.63M | Small cap | +11.80% |
| 4599.T | StemRIM | $140.21M | Small cap | +14.75% |
| CPIX | Cumberland Pharmaceuticals Inc. | $130.35M | Small cap | +163.82% |
| A2ZT34.SA | Azenta, Inc. | $120.48M | Small cap | +50.80% |
| SDI.AX | SDI Ltd | $119.34M | Small cap | +60.41% |
| ALECR.PA | Eurofins-Cerep SA | $107.03M | Small cap | −3.80% |
| 004080.KS | Shinhung Co., Ltd | $94.21M | Micro cap | +2.54% |
| RLYB | Rallybio Corporation | $89.64M | Micro cap | +257.63% |
| INIFY.OL | INIFY Laboratories AB | $81.09M | Micro cap | +44.55% |
| 7702.T | JMS Co.,Ltd. | $70.66M | Micro cap | +6.20% |
| SAR.L | Sareum Holdings plc | $70.10M | Micro cap | +76.19% |
| INCR | InterCure Ltd. | $69.65M | Micro cap | +265.03% |
| INMB | INmune Bio Inc. | $67.86M | Micro cap | +19.56% |
| RNXT | RenovoRx, Inc. | $67.24M | Micro cap | +61.08% |
| OHGR.L | One Health Group Plc | $53.82M | Micro cap | +17.03% |
| ENP.AX | Entropy Neurodynamics Limited | $48.13M | Micro cap | +10.81% |
| 7091.T | Living Platform,Ltd. | $36.16M | Micro cap | +34.42% |
| BFRI | Biofrontera Inc. | $22.72M | Micro cap | +77.91% |
| 7129.T | Miahelsa Holdings Corporation | $20.31M | Micro cap | +4.87% |
| 9220.T | FB Care Service Co.,Ltd. | $19.37M | Micro cap | +11.55% |
| APS.TO | Aptose Biosciences Inc | $4.41M | Micro cap | +50.00% |
| BION.SW | BB Biotech AG | — | — | +84.12% |
| BSLN.SW | Basilea Pharmaceutica AG | — | — | +40.88% |
| GXI.SW | Gerresheimer AG | — | — | +2.10% |
| LONN.SW | Lonza Group AG | — | — | +4.28% |
| NOVN.SW | Novartis AG | — | — | +30.24% |
| RO.SW | Roche Holding AG | — | — | +41.81% |
| ROP.SW | Roche Holding AG | — | — | +47.60% |
| SDZ.SW | Sandoz Group AG | — | — | +47.80% |
| SKAN.SW | SKAN Group AG | — | — | +6.80% |
| SOON.SW | Sonova Holding AG | — | — | +6.01% |
| TECN.SW | Tecan Group AG | — | — | +19.14% |
| YPSN.SW | Ypsomed Holding AG | — | — | +4.01% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.